US Stock MarketDetailed Quotes

EXAS Exact Sciences

Watchlist
  • 59.400
  • +3.290+5.86%
Close Dec 20 16:00 ET
  • 59.500
  • +0.100+0.17%
Post 20:01 ET
10.99BMarket Cap-51.21P/E (TTM)

Exact Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
12.78%708.66M
12.41%699.26M
5.82%637.52M
19.93%2.5B
16.98%646.89M
20.12%628.34M
19.26%622.09M
23.82%602.45M
17.95%2.08B
16.71%553M
Operating revenue
12.78%708.66M
12.41%699.26M
5.82%637.52M
19.93%2.5B
16.98%646.89M
20.12%628.34M
19.26%622.09M
23.82%602.45M
17.95%2.08B
16.71%553M
Cost of revenue
16.38%196.1M
20.89%189.8M
8.41%170.1M
13.89%654.2M
16.75%171.8M
13.90%168.5M
8.58%157M
16.48%156.9M
25.21%574.4M
23.60%147.16M
Gross profit
11.46%512.56M
9.54%509.46M
4.91%467.42M
22.23%1.85B
17.06%475.09M
22.58%459.84M
23.35%465.09M
26.62%445.55M
15.41%1.51B
14.40%405.84M
Operating expense
17.73%533.34M
-2.57%527.6M
9.00%569.69M
-1.32%2.06B
4.14%542.83M
-10.69%453.01M
2.17%541.52M
-1.18%522.65M
-2.63%2.09B
-9.53%521.28M
Selling and administrative expenses
5.45%411.9M
-6.59%387.2M
7.72%435.5M
2.34%1.62B
1.71%411M
2.88%390.6M
4.25%414.5M
0.57%404.3M
-4.80%1.58B
-12.85%404.09M
-Selling and marketing expense
23.46%54.2M
4.65%51.8M
-4.91%50.4M
-29.57%203.9M
-22.89%57.6M
-33.48%43.9M
-32.01%49.5M
-30.35%53M
-66.41%289.5M
-88.88%74.7M
-General and administrative expense
3.17%357.7M
-8.11%335.4M
9.62%385.1M
9.48%1.42B
7.29%353.4M
10.53%346.7M
12.38%365M
7.79%351.3M
61.47%1.29B
258.33%329.39M
Research and development costs
-10.18%100.1M
16.13%120.88M
15.92%110.61M
8.25%425.88M
21.90%114.92M
22.72%111.45M
-1.87%104.1M
-6.68%95.42M
2.02%393.42M
6.54%94.27M
Depreciation amortization depletion
6.28%24.44M
1.67%23.31M
1.67%23.31M
-5.43%92.16M
1.73%23.31M
-2.27%22.99M
-13.00%22.93M
-7.00%22.93M
2.58%97.45M
-4.71%22.91M
-Depreciation and amortization
6.28%24.44M
1.67%23.31M
1.67%23.31M
-5.43%92.16M
1.73%23.31M
-2.27%22.99M
-13.00%22.93M
-7.00%22.93M
2.58%97.45M
-4.71%22.91M
Other operating expenses
95.70%-3.1M
---3.8M
--268K
-692.17%-78.43M
---6.4M
-643.85%-72.03M
----
----
--13.24M
--0
Operating profit
-404.39%-20.78M
76.28%-18.13M
-32.64%-102.26M
62.89%-214.35M
41.31%-67.75M
105.17%6.83M
50.04%-76.43M
56.45%-77.1M
30.87%-577.53M
47.87%-115.44M
Net non-operating interest income expense
-22.06%-9.61M
101.42%111K
-293.40%-7.94M
-51.63%-29.77M
-45.38%-7.87M
-50.35%-7.87M
-73.31%-7.82M
202.29%4.11M
-5.53%-19.63M
-16.14%-5.41M
Non-operating interest income
----
----
----
----
----
----
----
--4.11M
----
----
Non-operating interest expense
26.46%8.27M
----
--7.94M
75.60%24.42M
64.76%6.54M
72.57%6.54M
----
----
7.98%13.91M
23.39%3.97M
Total other finance cost
0.38%1.33M
-101.42%-111K
----
-6.58%5.35M
-7.90%1.33M
-7.96%1.33M
--7.82M
----
0.00%5.73M
0.00%1.44M
Other net income (expense)
-444.60%-7.12M
-14.66%3.65M
319.71%1.77M
219.84%42.42M
379.36%25.33M
114.21%2.07M
141.47%4.28M
128.31%421K
-405.96%-35.39M
-823.05%-9.07M
Gain on sale of security
460.87%11.58M
144.43%11.8M
1,167.96%6.21M
268.41%32.71M
549.51%25.33M
124.06%2.07M
229.82%4.83M
132.95%490K
-161.13%-19.43M
-549.36%-5.64M
Special income (charges)
---18.7M
-1,376.81%-8.15M
-6,343.48%-4.45M
160.76%9.7M
--0
--0
91.62%-552K
---69K
20.98%-15.97M
---3.43M
-Less:Impairment of capital assets
--18.7M
1,376.81%8.15M
6,343.48%4.45M
-96.11%621K
--0
--0
-91.62%552K
--69K
-20.98%15.97M
--3.43M
-Less:Other special charges
----
----
----
---10.32M
--0
----
----
----
----
----
Income before tax
-3,688.49%-37.43M
82.05%-14.35M
-49.56%-108.42M
68.11%-201.75M
61.23%-50.38M
100.69%1.04M
52.38%-79.92M
60.38%-72.49M
24.92%-632.57M
42.22%-129.93M
Income tax
224.50%808K
32.16%1.46M
8.99%1.81M
126.51%2.4M
72.04%-610K
107.99%249K
163.22%1.11M
182.23%1.66M
96.33%-9.06M
48.57%-2.18M
Net income
-4,915.62%-38.24M
80.49%-15.81M
-48.65%-110.23M
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
Net income continuous Operations
-4,915.62%-38.24M
80.49%-15.81M
-48.65%-110.23M
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
Minority interest income
Net income attributable to the parent company
-4,915.62%-38.24M
80.49%-15.81M
-48.65%-110.23M
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-4,915.62%-38.24M
80.49%-15.81M
-48.65%-110.23M
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
Basic earnings per share
-4,878.16%-0.21
80.00%-0.09
-42.86%-0.6
68.08%-1.13
62.50%-0.27
100.52%0.0044
52.13%-0.45
59.62%-0.42
-1.72%-3.54
43.75%-0.72
Diluted earnings per share
-4,969.00%-0.21
80.00%-0.09
-42.86%-0.6
68.08%-1.13
62.50%-0.27
100.51%0.0043
52.13%-0.45
59.62%-0.42
-1.72%-3.54
43.75%-0.72
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 12.78%708.66M12.41%699.26M5.82%637.52M19.93%2.5B16.98%646.89M20.12%628.34M19.26%622.09M23.82%602.45M17.95%2.08B16.71%553M
Operating revenue 12.78%708.66M12.41%699.26M5.82%637.52M19.93%2.5B16.98%646.89M20.12%628.34M19.26%622.09M23.82%602.45M17.95%2.08B16.71%553M
Cost of revenue 16.38%196.1M20.89%189.8M8.41%170.1M13.89%654.2M16.75%171.8M13.90%168.5M8.58%157M16.48%156.9M25.21%574.4M23.60%147.16M
Gross profit 11.46%512.56M9.54%509.46M4.91%467.42M22.23%1.85B17.06%475.09M22.58%459.84M23.35%465.09M26.62%445.55M15.41%1.51B14.40%405.84M
Operating expense 17.73%533.34M-2.57%527.6M9.00%569.69M-1.32%2.06B4.14%542.83M-10.69%453.01M2.17%541.52M-1.18%522.65M-2.63%2.09B-9.53%521.28M
Selling and administrative expenses 5.45%411.9M-6.59%387.2M7.72%435.5M2.34%1.62B1.71%411M2.88%390.6M4.25%414.5M0.57%404.3M-4.80%1.58B-12.85%404.09M
-Selling and marketing expense 23.46%54.2M4.65%51.8M-4.91%50.4M-29.57%203.9M-22.89%57.6M-33.48%43.9M-32.01%49.5M-30.35%53M-66.41%289.5M-88.88%74.7M
-General and administrative expense 3.17%357.7M-8.11%335.4M9.62%385.1M9.48%1.42B7.29%353.4M10.53%346.7M12.38%365M7.79%351.3M61.47%1.29B258.33%329.39M
Research and development costs -10.18%100.1M16.13%120.88M15.92%110.61M8.25%425.88M21.90%114.92M22.72%111.45M-1.87%104.1M-6.68%95.42M2.02%393.42M6.54%94.27M
Depreciation amortization depletion 6.28%24.44M1.67%23.31M1.67%23.31M-5.43%92.16M1.73%23.31M-2.27%22.99M-13.00%22.93M-7.00%22.93M2.58%97.45M-4.71%22.91M
-Depreciation and amortization 6.28%24.44M1.67%23.31M1.67%23.31M-5.43%92.16M1.73%23.31M-2.27%22.99M-13.00%22.93M-7.00%22.93M2.58%97.45M-4.71%22.91M
Other operating expenses 95.70%-3.1M---3.8M--268K-692.17%-78.43M---6.4M-643.85%-72.03M----------13.24M--0
Operating profit -404.39%-20.78M76.28%-18.13M-32.64%-102.26M62.89%-214.35M41.31%-67.75M105.17%6.83M50.04%-76.43M56.45%-77.1M30.87%-577.53M47.87%-115.44M
Net non-operating interest income expense -22.06%-9.61M101.42%111K-293.40%-7.94M-51.63%-29.77M-45.38%-7.87M-50.35%-7.87M-73.31%-7.82M202.29%4.11M-5.53%-19.63M-16.14%-5.41M
Non-operating interest income ------------------------------4.11M--------
Non-operating interest expense 26.46%8.27M------7.94M75.60%24.42M64.76%6.54M72.57%6.54M--------7.98%13.91M23.39%3.97M
Total other finance cost 0.38%1.33M-101.42%-111K-----6.58%5.35M-7.90%1.33M-7.96%1.33M--7.82M----0.00%5.73M0.00%1.44M
Other net income (expense) -444.60%-7.12M-14.66%3.65M319.71%1.77M219.84%42.42M379.36%25.33M114.21%2.07M141.47%4.28M128.31%421K-405.96%-35.39M-823.05%-9.07M
Gain on sale of security 460.87%11.58M144.43%11.8M1,167.96%6.21M268.41%32.71M549.51%25.33M124.06%2.07M229.82%4.83M132.95%490K-161.13%-19.43M-549.36%-5.64M
Special income (charges) ---18.7M-1,376.81%-8.15M-6,343.48%-4.45M160.76%9.7M--0--091.62%-552K---69K20.98%-15.97M---3.43M
-Less:Impairment of capital assets --18.7M1,376.81%8.15M6,343.48%4.45M-96.11%621K--0--0-91.62%552K--69K-20.98%15.97M--3.43M
-Less:Other special charges ---------------10.32M--0--------------------
Income before tax -3,688.49%-37.43M82.05%-14.35M-49.56%-108.42M68.11%-201.75M61.23%-50.38M100.69%1.04M52.38%-79.92M60.38%-72.49M24.92%-632.57M42.22%-129.93M
Income tax 224.50%808K32.16%1.46M8.99%1.81M126.51%2.4M72.04%-610K107.99%249K163.22%1.11M182.23%1.66M96.33%-9.06M48.57%-2.18M
Net income -4,915.62%-38.24M80.49%-15.81M-48.65%-110.23M67.26%-204.15M61.04%-49.77M100.53%794K51.21%-81.03M59.02%-74.15M-4.68%-623.51M42.09%-127.75M
Net income continuous Operations -4,915.62%-38.24M80.49%-15.81M-48.65%-110.23M67.26%-204.15M61.04%-49.77M100.53%794K51.21%-81.03M59.02%-74.15M-4.68%-623.51M42.09%-127.75M
Minority interest income
Net income attributable to the parent company -4,915.62%-38.24M80.49%-15.81M-48.65%-110.23M67.26%-204.15M61.04%-49.77M100.53%794K51.21%-81.03M59.02%-74.15M-4.68%-623.51M42.09%-127.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -4,915.62%-38.24M80.49%-15.81M-48.65%-110.23M67.26%-204.15M61.04%-49.77M100.53%794K51.21%-81.03M59.02%-74.15M-4.68%-623.51M42.09%-127.75M
Basic earnings per share -4,878.16%-0.2180.00%-0.09-42.86%-0.668.08%-1.1362.50%-0.27100.52%0.004452.13%-0.4559.62%-0.42-1.72%-3.5443.75%-0.72
Diluted earnings per share -4,969.00%-0.2180.00%-0.09-42.86%-0.668.08%-1.1362.50%-0.27100.51%0.004352.13%-0.4559.62%-0.42-1.72%-3.5443.75%-0.72
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Cancer Research
Cancer Research
Intraday+0.56%